February 25, 2009 – Nancy Soto has been named the new director of the Protocol Development and Regulatory Compliance Department of the Radiation Therapy Oncology Group (RTOG).
Ms. Soto will direct RTOG’s protocol development, patient registration, on-site auditing and regulatory compliance activities. RTOG is a National Cancer Institute-funded national clinical trials group and is administered by the American College of Radiology.
“Ms. Soto is a valuable addition to the RTOG administrative staff,” said Walter J. Curran, Jr., M.D., the RTOG Group Chair, and the Lawrence W. Davis Professor and Chair of the Department of Radiation Oncology in the Emory School of Medicine and Chief Medical Officer of the Emory Winship Cancer Institute. “Her background in clinical trial research in both the corporate and academic arenas have allowed her to hit-the-ground running at RTOG headquarters.”
Prior to coming to RTOG, Ms. Soto spent 17 years with Memorial Sloan Kettering Cancer Center in New York working in grants management and clinical trial research coordination. Most recently Ms. Soto was with Schering-Plough Corporation in their Oncology Phase IV Global Clinical Trials Management section where she was a clinical project manager for investigator-initiated studies. Ms. Soto replaces Wilma Hoffman who was promoted to the position of RTOG Senior Director last year.
For more information: www.acr.org
July 31, 2026 
